MEDP SEC Filings: 8-K, 10-Q, S-3 & 424B – Medpace

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 22, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 23, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Apr 23, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 23, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 22, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Medpace Holdings, Inc. Reports Third Quarter 2026 Results and Announces New $1.0 Billion Stock Repurchase Authorization

Oct 21, 2026

8-K

Medpace Holdings, Inc. Reports Second Quarter 2026 Financial Results

Jul 22, 2026

8-K

Medpace Holdings, Inc. Appoints Brad W. Hansman as Executive Vice President, Operations

Jun 4, 2026

8-K

Medpace Holdings, Inc. Announces Results of 2026 Annual Meeting and Governance Amendments

May 19, 2026

8-K

Medpace Holdings, Inc. Reports First Quarter 2026 Financial Results

Apr 22, 2026

8-K

Medpace Holdings, Inc. Reports Robust Q4 and Full Year 2025 Financial Results

Feb 9, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B7

5,224,997 Shares

Aug 24, 2018

424B7

5,224,997 Shares

Aug 22, 2018

424B7

4,500,000 Shares

Aug 9, 2018

424B7

4,500,000 Shares

Aug 7, 2018

424B7

3,000,000 Shares

Jun 13, 2018

424B7

3,000,000 Shares

Jun 11, 2018

Registrations

TYPE

HEADLINE

FILED AT

S-3ASR

7,289,662 Shares

Feb 14, 2023

POS AM

Registration

Feb 25, 2020

S-3ASR

8,584,258 Shares

Feb 25, 2020

SC TO-T/A

Options to Purchase Common Stock, Par Value $0.01 Per Share

Sep 17, 2019

SC TO-T/A

Options to Purchase Common Stock, Par Value $0.01 Per Share

Aug 15, 2019

SC TO-T/A

Options to Purchase Common Stock, Par Value $0.01 Per Share

Aug 7, 2019

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 1, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 1, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 16, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 2, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 2, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 3, 2024

Ownerships

TYPE

HEADLINE

FILED AT

EWALD STEPHEN P (Reporting)

Nov 2, 2026

144

Form 144 - Report of proposed sale of securities

Oct 29, 2026

BURWIG SUSAN E (Reporting)

Oct 28, 2026

144

Form 144 - Report of proposed sale of securities

Oct 27, 2026

144

Form 144 - Report of proposed sale of securities

Oct 26, 2026

BURWIG SUSAN E (Reporting)

Oct 23, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Mar 6, 2020

LETTER